124 related articles for article (PubMed ID: 9848725)
1. Transforming growth factor-beta1 resistance in a thyroid cancer model of tumor necrosis factor-alpha resistance.
Pang XP; Hershman JM
Thyroid; 1998 Nov; 8(11):1065-70. PubMed ID: 9848725
[TBL] [Abstract][Full Text] [Related]
2. Alterations in TNF-alpha signal transduction in resistant human papillary thyroid carcinoma cells.
Pang XP; Ross NS; Hershman JM
Thyroid; 1996 Aug; 6(4):313-7. PubMed ID: 8875753
[TBL] [Abstract][Full Text] [Related]
3. TNF-alpha-induced antiproliferation is not dependent on the autocrine action of TGF-beta 1 in a thyroid cancer cell line.
Pang XP; Yoshimura M; Wang J; Dubinett SM
Lymphokine Cytokine Res; 1994 Apr; 13(2):93-7. PubMed ID: 8061120
[TBL] [Abstract][Full Text] [Related]
4. Potential role of transforming growth factor beta1 in drug resistance of tumor cells.
Stoika R; Yakymovych M; Souchelnytskyi S; Yakymovych I
Acta Biochim Pol; 2003; 50(2):497-508. PubMed ID: 12833174
[TBL] [Abstract][Full Text] [Related]
5. Correlation between suppression of c-myc and antiproliferative effect of transforming growth factor-beta 1 in thyroid carcinoma cell growth.
Usa T; Tsukazaki T; Namba H; Ohtsuru A; Kimura H; Villadolid MC; Nagataki S; Yamashita S
Endocrinology; 1994 Oct; 135(4):1378-84. PubMed ID: 7925100
[TBL] [Abstract][Full Text] [Related]
6. Antitumor actions of cytokines on new human papillary thyroid carcinoma cell lines.
Ohta K; Pang XP; Berg L; Hershman JM
J Clin Endocrinol Metab; 1996 Jul; 81(7):2607-12. PubMed ID: 8675585
[TBL] [Abstract][Full Text] [Related]
7. TGF-beta1 inhibits the release of histamine and tumor necrosis factor-alpha from mast cells through an autocrine pathway.
Bissonnette EY; Enciso JA; Befus AD
Am J Respir Cell Mol Biol; 1997 Mar; 16(3):275-82. PubMed ID: 9070612
[TBL] [Abstract][Full Text] [Related]
8. Growth stimulation of murine fibroblasts by TGF-beta1 depends on the expression of a functional p53 protein.
Dkhissi F; Raynal S; Jullien P; Lawrence DA
Oncogene; 1999 Jan; 18(3):703-11. PubMed ID: 9989820
[TBL] [Abstract][Full Text] [Related]
9. Combination of tumor necrosis factor alpha and interferon alpha induces apoptotic cell death through a c-myc-dependent pathway in p53 mutant H226br non-small-cell lung cancer cell line.
Yasuoka Y; Naomoto Y; Yamatsuji T; Takaoka M; Kimura M; Uetsuka H; Matsubara N; Fujiwara T; Gunduz M; Tanaka N; Haisa M
Exp Cell Res; 2001 Dec; 271(2):214-22. PubMed ID: 11716533
[TBL] [Abstract][Full Text] [Related]
10. Tumor necrosis factor-alpha (TNF-alpha) and transforming growth factor-beta 1 (TGF-beta 1) inhibit the expression and activity of Na+/K(+)-ATPase in FRTL-5 rat thyroid cells.
Pekary AE; Levin SR; Johnson DG; Berg L; Hershman JM
J Interferon Cytokine Res; 1997 Apr; 17(4):185-95. PubMed ID: 9142647
[TBL] [Abstract][Full Text] [Related]
11. Can transforming growth factor-beta1 and retinoids modify the activity of estradiol and antiestrogens in MCF-7 breast cancer cells?
Czeczuga-Semeniuk E; Anchim T; Dziecioł J; Dabrowska M; Wołczyński S
Acta Biochim Pol; 2004; 51(3):733-45. PubMed ID: 15448735
[TBL] [Abstract][Full Text] [Related]
12. Bone morphogenic protein-7 inhibits monocyte-stimulated TGF-beta1 generation in renal proximal tubular epithelial cells.
Zhang XL; Selbi W; de la Motte C; Hascall V; Phillips AO
J Am Soc Nephrol; 2005 Jan; 16(1):79-89. PubMed ID: 15574511
[TBL] [Abstract][Full Text] [Related]
13. [New insight into the mechanism of p53 inducing leukemia cell apoptosis].
Chen YZ; Wu Y; Liang M; Li NN; Zhang ZX; Lu LH
Zhonghua Xue Ye Xue Za Zhi; 2003 Dec; 24(12):640-3. PubMed ID: 14761612
[TBL] [Abstract][Full Text] [Related]
14. Transforming growth factor-beta1 and activin A generate antiproliferative signaling in thyroid cancer cells.
Matsuo SE; Leoni SG; Colquhoun A; Kimura ET
J Endocrinol; 2006 Jul; 190(1):141-50. PubMed ID: 16837618
[TBL] [Abstract][Full Text] [Related]
15. Differential effects of TGF-beta1 on telomerase activity in thyroid carcinoma cell lines.
Lindkvist A; Franzén A; Ren ZP; Heldin NE; Paulsson-Karlsson Y
Biochem Biophys Res Commun; 2005 Dec; 338(3):1625-33. PubMed ID: 16288728
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of regucalcin suppresses cell response for tumor necrosis factor-alpha or transforming growth factor-beta1 in cloned normal rat kidney proximal tubular epithelial NRK52E cells.
Nakagawa T; Yamaguchi M
J Cell Biochem; 2007 Apr; 100(5):1178-90. PubMed ID: 17063480
[TBL] [Abstract][Full Text] [Related]
17. Tumor necrosis factor-α inhibits transforming growth factor-β-stimulated myofibroblastic differentiation and extracellular matrix production in human gingival fibroblasts.
Arancibia R; Oyarzún A; Silva D; Tobar N; Martínez J; Smith PC
J Periodontol; 2013 May; 84(5):683-93. PubMed ID: 22813343
[TBL] [Abstract][Full Text] [Related]
18. Tumor necrosis factor, ceramide, transforming growth factor-beta1, and aging reduce Na+/I- symporter messenger ribonucleic acid levels in FRTL-5 cells.
Pekary AE; Hershman JM
Endocrinology; 1998 Feb; 139(2):703-12. PubMed ID: 9449644
[TBL] [Abstract][Full Text] [Related]
19. Resveratrol induces apoptosis in thyroid cancer cell lines via a MAPK- and p53-dependent mechanism.
Shih A; Davis FB; Lin HY; Davis PJ
J Clin Endocrinol Metab; 2002 Mar; 87(3):1223-32. PubMed ID: 11889192
[TBL] [Abstract][Full Text] [Related]
20. Substantial changes in gene expression of Wnt, MAPK and TNFalpha pathways induced by TGF-beta1 in cervical cancer cell lines.
Kloth JN; Fleuren GJ; Oosting J; de Menezes RX; Eilers PH; Kenter GG; Gorter A
Carcinogenesis; 2005 Sep; 26(9):1493-502. PubMed ID: 15878915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
